Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort

OBJECTIVE: We aimed to establish and validate two nomograms that predict progression‐free survival (PFS) and overall survival (OS) in patients with stage II–IVa nasopharyngeal carcinoma (NPC) while evaluating the benefit of concurrent chemotherapy. PATIENTS AND METHODS: We randomly divided 3412 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xue‐Song, Xiao, Bei‐Bei, Lin, Chao, Liu, Sai‐Lan, Chen, Qiu‐Yan, Tang, Lin‐Quan, Mai, Hai‐Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050092/
https://www.ncbi.nlm.nih.gov/pubmed/31925942
http://dx.doi.org/10.1002/cam4.2841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050092/
https://www.ncbi.nlm.nih.gov/pubmed/31925942
http://dx.doi.org/10.1002/cam4.2841

Ejemplares similares